Guggenheim lifts AstraZeneca stock target, buy rating on prospects
Guggenheim adjusted its price target on shares of AstraZeneca (NASDAQ:AZN:LN) (NASDAQ: AZN), increasing it to GBP13,100 from ...
The incredible £820m new museum being built on an island in huge city
This massive new museum that is opening in the world's wealthiest city will feature remarkable art collections for across the ...
Guggenheim cuts Merck stock target, retains Buy on revised estimates
Co Inc (NYSE:MRK) shares, reducing the pharmaceutical giant's price target from $130.00 to $122.00 while reaffirming a Buy rating on the stock. The revision by Guggenheim analyst is primarily due to ...
bleedingcool3d
Arrowverse: Marc Guggenheim Auctioning Signed Scripts for CA Relief
Marc Guggenheim is auctioning signed Arrow, Legends of Tomorrow, and "Arrowverse" crossover scripts to help fund important ...
Yahoo Finance2d
Guggenheim Strategic Opportunities Fund (GOF)
NEW YORK, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Guggenheim Investments today announced that certain closed-end funds have declared their distributions. The table below summarizes the distribution ...
Merck price target lowered to $122 from $130 at Guggenheim
Guggenheim analyst Vamil Divan lowered the firm’s price target on Merck (MRK) to $122 from $130 and keeps a Buy rating on the shares. The firm ...
Orphism, the early 20th century art movement, in focus at New York’s Guggenheim Museum
The exhibition spotlights a contradictory modern art movement that, though it celebrated technological advances, was rooted ...
Guggenheim Sticks to Its Buy Rating for Paramount Global Class B (PARA)
In a report released on January 8, Michael Morris from Guggenheim maintained a Buy rating on Paramount Global Class B (PARA – Research Report), ...
Guggenheim Doubts Salesforce's Agentic AI Agentforce as an Effective Growth Factor
Agentforce was launched in September and already signed up 200 companies to deploy Agentforce as their smarter chatbot. Marc ...